ABSTRACT
SUMMARY OBJECTIVE: To assess the prevalence of maternal alloantibodies in pregnant women at a maternity hospital in northeastern Brazil and describe their perinatal outcomes. METHODS: A retrospective cohort study reviewed maternal and newborn medical records between January 2017 and October 2018 to assess for the presence of maternal alloantibodies. RESULTS: The following maternal alloantibodies were found in the 41 cases surveyed: anti-D, 28 cases (45%); anti-C, 7 cases (11%); anti-c, 1 case (1.6%); anti-E, 4 cases (6.4%); anti-Cw, 1 case (1.6%); anti-K, 2 cases (3.2%); anti-Jka, 1 case (1.6%); anti-M, 3 cases (4.8%); anti-Fya, 2 cases (3.2%); anti-Fyb, 1 case (1.6%); anti-Lea, 5 cases (8%); anti-Leb, 3 cases (4.8%); and anti-Dia, 4 cases (6.4%). Anti-D antibodies were the most frequent cause of erythrocyte alloimmunization (80%). Fetal anemia was observed in four pregnancies based on the peak systolic velocity of the middle cerebral artery. In one case, the mother showed anti-M, and anti-Lea alloimmunization, but the direct antiglobulin test results for the newborn were negative, and no unfavorable neonatal outcomes were observed. In one case of a mother with anti-C and anti-D alloimmunization, the neonate showed anti-D antibodies only in the serological panel and required phototherapy. Neonates with plasma antibodies and jaundice requiring phototherapy only had a serological panel with anti-D, anti-C, anti-c, and anti-E antibodies. Intervention was required for 2.5% of pregnant women with positive antibody screens and 81% of newborns with positive direct antiglobulin test results. CONCLUSION: Despite being a rare condition, maternal alloimmunization by irregular antibodies can result in high perinatal morbidity and mortality.
ABSTRACT
Resumen Introducción: El sistema Kell está formado por dos antígenos principales: el Kell (K) y el Cellano (k), estos son capaces de causar reacciones graves, tales como reacción hemolítica postransfusional y la enfermedad hemolítica del recién nacido. Los antígenos de este sistema son altamente inmunogénicos lo que les confiere el tercer lugar en importancia clínica. Objetivo: Determinar la frecuencia del antígeno Kell y procedencia de las mujeres donantes de sangre con antígeno Kell positivo en el Hemocentro del Centro Oriente Colombiano (HCOC). Metodología: Estudio descriptivo de corte transversal que incluyó 186 donantes voluntarias de sangre del Hemocentro Centro Oriente Colombiano, se realizó la fenotipificación del antígeno Kell, utilizando la técnica Aglutinación en lámina, la cual se basa en enfrentar glóbulos rojos del donante con anticuerpo monoclonal anti K. Se calculó la frecuencia fenotípica del antígeno Kell, en porcentajes y para el procesamiento de la información se utilizó el paquete estadístico SPSS versión 21.0 en español donde se realizó todo el análisis de los datos de la población. Resultados: Se procesaron 177 muestras obtenidas en 9 campañas de donación de sangre realizadas en diferentes municipios del departamento de Boyacá, obteniéndose una frecuencia fenotípica del 7,5% para el antígeno Kell, en la población de mujeres donantes de sangre del HCOC, siendo esta similar con la frecuencia encontrada en Colombia y Latinoamérica. Conclusión: Se determinó que la frecuencia del antígeno Kell en las mujeres donantes de sangre del HCOC fue del 7,5%, y se logró identificar que no existe una relación estadísticamente entre la procedencia y la presencia del antígeno Kell en las donantes, lo anterior está relacionado con el mestizaje y los procesos de migración.
Abstract Introduction: The Kell system consists of two major antigens: Kell (K) and Cellano (K), which are capable of causing serious reactions, such as posttransfusion hemolytic reaction and hemolytic disease of the newborn. The antigens of this system are highly immunogenic which gives them the third place in clinical importance. Objective: To determine the frequency of Kell antigen and origin of blood donors in the Hemocenter of the Centro Oriente Colombiano (H.C.O.C). Methods: Cross-sectional descriptive study involving 186 blood donors from the Centro Oriente Colombian Hemocenter, phenotyping of the Kell antigen was carried out, using the technique Aglutination in lamina, which is based on facing donor red blood cells with anti-K monoclonal antibody. Calculated the phenotypic frequency of the Kell antigen in percentages and for the processing of the information was used the statistical package SPSS version 21.0 in Spanish where all the analysis of the data of the population was carried out. Results: 177 samples obtained in 9 blood donation campaigns were carried out in different municipalities of the department of Boyacá, obtaining a phenotypic frequency of 7.5% for the Kell antigen in the population of female HCOC blood donors. Similar to the frequency found in Colombia and Latin America. Conclusion: It was determined that the frequency of Kell antigen in the female HCOC donors was 7.5%, and it was possible to identify that there is no statistically relation between the origin and the presence of Kell antigen in the donors, Is related to mestizaje and migration processes.
Subject(s)
Humans , Female , Blood , Blood Donors , Kell Blood-Group System , Antibodies, Monoclonal , Antigens , Tissue Donors , Agglutination , Erythroblastosis, FetalABSTRACT
Jr(a) is a high-frequency antigen found in all ethnic groups. However, the clinical significance of the anti-Jr(a) antibody has remained controversial. Most studies have reported mild hemolytic disease of the newborn and fetus (HDNF) in Jr(a)-positive patients. Recently, fatal cases of HDNF have also been reported. We report the first case of HDNF caused by anti-Jr(a) alloimmunization in twins in Korea. A 33-yr-old nulliparous woman with no history of transfusion or amniocentesis was admitted at the 32nd week of gestation because of vaginal bleeding caused by placenta previa. Anti-Jr(a) antibodies were detected in a routine laboratory examination. An emergency cesarean section was performed at the 34th week of gestation, and 2 premature infant twins were delivered. Laboratory examination showed positive direct antiglobulin test and Jr(a+) phenotype in the red blood cells and the presence of anti-Jr(a) antibodies in the serum in both neonates. The infants underwent phototherapy for neonatal jaundice; this was followed by conservative management. They showed no further complications and were discharged on the 19th postpartum day. Preparative management to ensure the availability of Jr(a-) blood, via autologous donation, and close fetal monitoring must be performed even in cases of first pregnancy in Jr(a-) women.
Subject(s)
Adult , Female , Humans , Infant, Newborn , Male , Pregnancy , Blood Group Antigens/immunology , Blood Group Incompatibility , Diseases in Twins/diagnosis , Erythroblastosis, Fetal/diagnosis , Gestational Age , Isoantigens/immunology , Jaundice, Neonatal/complications , Phenotype , Phototherapy , Pregnancy Complications, Hematologic/diagnosis , TwinsABSTRACT
Considerando a utilização de bases administrativas na vigilância epidemiológica, propõe-se aqui avaliar a adequação do Sistema de Informações Hospitalares do Sistema Único de Saúde (SIH-SUS) na identificação dos casos de doença hemolítica perinatal ocorridos no Instituto Fernandes Figueira, Fundação Oswaldo Cruz (IFF/FIOCRUZ), entre 1998 e 2003. Foram analisadas informações disponibilizadas pelo Serviço Neonatal, pelo Arquivo Médico e os dados da Autorização de Internação Hospitalar (AIH) consolidados no SIH-SUS. A identificação dos casos de doença hemolítica perinatal se deu através dos campos Diagnóstico Primário, Diagnóstico Secundário e Procedimento Realizado. Nesse período, 194 neonatos foram diagnosticados com doença hemolítica perinatal. No Arquivo Médico, 148 casos foram registrados, porém apenas 147 AIHs foram emitidas e 145 consolidadas no SIH-SUS. Entre essas, 84 AIHs arrolavam a doença hemolítica perinatal como Diagnóstico Primário; considerando também o Diagnóstico Secundário, mais 38 casos foram identificados; e nenhum caso adicional foi recuperado pelo Procedimento Realizado. Assim, o SIH-SUS identificou apenas 122 (62,9 por cento) dos 194 neonatos com doença hemolítica perinatal assistidos no IFF/FIOCRUZ. Mesmo que ainda requerendo uma reavaliação em outros hospitais, a utilização do SIH-SUS no monitoramento da doença hemolítica perinatal não parece recomendável. Estudos ancilares são necessários quando do emprego de dados secundários nesse contexto.
This study aimed to evaluate the adequacy of the Hospital Information System of the National Unified Health System (SIH-SUS) in identifying cases of RhD hemolytic disease of the newborn (HDN) at the Fernandes Figueira Institute (IFF/FIOCRUZ) from 1998 to 2003. Neonatal records, data from the Medical Archives, and AIH (Hospital Admissions Authorization Form) data consolidated in the SIH-SUS were analyzed. Cases were identified according to the following fields: principal diagnosis, secondary diagnosis, and procedure performed. During the period studied, 194 cases of HDN were diagnosed. The Medical Archives registered 148 newborns with HDN, however only 147 AIHs were issued and 145 consolidated in the SIH-SUS. Among these 145 cases, 84 cited HDN as the principal diagnosis, while secondary diagnosis identified 38 additional cases and the procedures performed failed to identify any further cases. Thus, the SIH-SUS identified only 122 (62.9 percent) of the 194 cases of HDN treated at the IFF/FIOCRUZ. Although it is necessary to evaluate other units, the SIH-SUS does not appear to be reliable for monitoring HDN. Additional studies are essential for employing secondary administrative data in the context of epidemiological surveillance.
Subject(s)
Humans , Female , Pregnancy , Infant, Newborn , Anemia, Hemolytic , Erythroblastosis, Fetal/diagnosis , Hospital Information Systems , Perinatal Care , Unified Health System , Health Services Research , BrazilABSTRACT
Fetal erythroblastosis caused by maternal Rhesus alloimmunization brings a significant clinical problem, eventually leading to fetal hydrops and intrauterine fetal death. Repeated blood transfusions into the umbilical vein are the treatment of choice for fetal erythroblastosis with severe hydrops. The purpose of this report is to introduce our experience with a case of fetal erythroblastosis, recovered after intraumbilical venous transfusions. The fetus has been received the intraumbilical venous transfusions for four times from 29 weeks of gestation. Fetal hydrops and cardiomegaly, as well as polyhydramnios were improved markedly after transfusions. A healthy baby was delivered at 34 weeks of gestation. Intraumbilical venous transfusion may be a safe and effective treatment on the case with severe aggressive anemic and hydropic isoimmune fetus.